- Home
- PPLI vs OPCH Comparison
PPLI vs OPCH Comparison
Compare PPLI & OPCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$38.53
HOLD
Current Price
$23.29
Company Overview
Basic Information| Metric | PPLI | OPCH |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Medical/Nursing Services |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 3.5B |
| IPO Year | 2020 | 1996 |
Fundamental Metrics
Financial Performance| Metric | PPLI | OPCH |
|---|---|---|
| Price | $38.53 | $23.29 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $36.57 |
| AVG Volume (30 Days) | 1.0M | ★ 2.5M |
| Earning Date | N/A | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 79.97 | 3.25 |
| EPS | ★ 5.65 | 0.29 |
| Revenue | $4,365,235,000.00 | ★ $4,998,202,000.00 |
| Revenue This Year | N/A | $7.21 |
| Revenue Next Year | N/A | $8.55 |
| P/E Ratio | ★ $6.93 | $80.72 |
| Revenue Growth | N/A | ★ 16.17 |
| 52 Week Low | $39.14 | $18.01 |
| 52 Week High | $48.32 | $36.80 |
Technical Indicators
Market Signals| Indicator | PPLI | OPCH |
|---|---|---|
| Relative Strength Index (RSI) | 36.98 | 53.62 |
| Support Level | N/A | $20.75 |
| Resistance Level | $47.96 | $24.83 |
| Average True Range (ATR) | 1.52 | 0.64 |
| MACD | -0.31 | -0.08 |
| Stochastic Oscillator | 0.69 | 45.23 |
Price Performance
Historical Comparison PPLI
OPCH
About PPLI People Incorporated Common Stock
People Inc is a media and publishing business that operates a portfolio of brands, including PEOPLE, Food & Wine, Travel + Leisure, InStyle, Better Homes & Gardens, and Southern Living. The company also holds a minority equity stake in MGM Resorts International.
About OPCH Option Care Health Inc.
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders, among others. The Company operates in one segment, infusion services.